Related Experiment Video
Updated: Sep 2, 2025

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Functional role of miR-34a in diabetes and frailty
Pasquale Mone1,2, Antonio de Donato3, Fahimeh Varzideh1
1Division of Cardiology, Department of Medicine, Albert Einstein College of Medicine, New York, NY, United States.
Abstract:
Emerging evidence has shown that microRNAs (miRNAs) play critical role in the pathogenesis of several disorders. In the present minireview, we focus our attention on the functional role of a specific miRNA, namely miR-34a, in the pathophysiology of frailty and diabetes mellitus. Based on the current literature, we speculate that this miRNA may serve as a potential biomarker of frailty in diabetic older adults. Additionally, its actions on oxidative stress might represent a druggable target to obtain new potentials treatments.
Insights
MicroRNAs (miRNAs) are key in disease. This review highlights miR-34a
Area of Science:
- Biomedical research
- Molecular biology
- Gerontology
Background:
- MicroRNAs (miRNAs) are crucial regulators of gene expression.
- Emerging evidence implicates miRNAs in various disease processes.
- Frailty and diabetes mellitus are significant health concerns, particularly in aging populations.
Purpose of the Study:
- To review the role of miR-34a in the pathophysiology of frailty.
- To examine the involvement of miR-34a in diabetes mellitus.
- To explore miR-34a as a potential biomarker and therapeutic target.
Main Methods:
- Literature review of current scientific publications.
- Analysis of existing data on miRNA function in disease.
- Synthesis of evidence regarding miR-34a's role in frailty and diabetes.
Main Results:
- miR-34a is implicated in the pathogenesis of both frailty and diabetes mellitus.
- miR-34a may serve as a potential biomarker for frailty in older adults with diabetes.
- miR-34a influences oxidative stress pathways relevant to these conditions.
Conclusions:
- miR-34a is a significant factor in the pathophysiology of frailty and diabetes.
- This miRNA presents potential as a biomarker for frailty in diabetic elderly individuals.
- Targeting miR-34a's effects on oxidative stress may offer novel therapeutic strategies.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Psychoneuroimmunology: Diabetes and Cancer
Mitochondria
MicroRNAs
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Regulation of Metabolism

